Placebo response rates in randomized controlled trials for perianal Crohn's disease: A systematic review and meta-analysis.

Placebo response and remission rates in pCD trials are influenced by patient and disease-related factors, as well as the type of intervention being studied. These contemporary rates will inform trial design for novel therapeutics.